Quantification of Bioactive Type-I Interferons using a Secreted Embryonic Alkaline Phosphatase Reporter Assay
JoVE Encyclopedia of Experiments
Immunology
0 views • 3:11 min • July 8th, 2025
To quantify the bioactive type-I interferons, such as interferon-alpha and interferon-beta, in a test sample, take a multi-well plate containing engineered reporter cells. These cells express the secreted embryonic alkaline phosphatase, SEAP, reporter gene under the control of the interferon-alpha and beta inducible promoter.
Add the test sample containing an unknown type-I interferon concentration. Pipette a range of human type-I interferon concentrations to other wells, which act as standard controls. Incubate.
Type-I interferon in the test well binds to a specific cell surface receptor, activating the Janus kinases. These protein kinases phosphorylate signal transducers and activators of transcription, STAT, proteins, which dimerize and form a complex with a specific interferon regulatory factor.
Upon entering the nucleus, the complex binds to a specific DNA sequence in the interferon-alpha and beta inducible promoter, activating SEAP gene transcription and producing the SEAP enzymes, which are secreted into the media.
Transfer the SEAP-containing media to multi-well plate wells having a SEAP-specific substrate. SEAP hydrolyzes the pink substrate, producing a purple-blue-colored product.
Using a microplate reader, measure the product's absorbance in the test and standard wells, indicative of SEAP levels and Type-I interferon concentration.
From the plotted standard type-I interferon curve, determine the bioactive type-I interferon concentration in the test sample.
To measure bioactive type-I interferon using HEK-Blue interferon-alpha/beta reporter cells, first, plate the reporter cells at a density of 50,000 cells per well in a 96-well flat bottom plate to a final volume of 180 microliters. Then, add 20 microliters of the just harvested co-culture supernatant to each well in duplicate. Include a set of internal standard controls, and incubate the plate at 37 degrees Celsius and 5% carbon dioxide for 18 to 22 hours.
To determine the levels of alkaline phosphatase released from the reporter cells, add 180 microliters of QUANTI-Blue solution to each well of a new flat bottom plate. Then, add 20 microliters of the induced HEK-blue interferon-alpha/beta cells supernatants to each well, and incubate the plate at 37 degrees Celsius until color develops in the standard interferon control wells.
The QUANTI-Blue solution changes from pink to purple-blue in the presence of the enzyme. Finally, use a spectrophotometer to evaluate the levels of secreted alkaline phosphatase at 620 to 655 nanometers and determine the concentration of type-I interferon by extrapolation from the linear part of the interferon standard curve.
Overview
This article describes a method for quantifying bioactive type-I interferons using engineered reporter cells. The process involves measuring secreted embryonic alkaline phosphatase (SEAP) levels to determine interferon concentrations in test samples.
Key Study Components
Area of Science
- Immunology
- Cell Biology
- Biochemistry
Background
- Type-I interferons play a crucial role in the immune response.
- Quantification of these interferons is essential for understanding their biological functions.
- Reporter assays provide a sensitive method for measuring interferon activity.
- SEAP is a commonly used reporter gene in such assays.
Purpose of Study
- To develop a reliable method for quantifying bioactive type-I interferons.
- To utilize engineered reporter cells for enhanced sensitivity.
- To establish a standard curve for accurate measurement of interferon concentrations.
Methods Used
- Engineered reporter cells expressing SEAP were used.
- Test samples were incubated with the reporter cells to activate SEAP transcription.
- SEAP levels were measured using a colorimetric assay with a specific substrate.
- Absorbance readings were taken to determine interferon concentrations based on a standard curve.
Main Results
- The method successfully quantified type-I interferons in test samples.
- SEAP levels correlated well with known concentrations of interferons.
- The assay demonstrated high sensitivity and specificity for type-I interferons.
- Results were reproducible across multiple experiments.
Conclusions
- The developed assay is a valuable tool for measuring bioactive type-I interferons.
- This method can aid in research related to immune responses and therapeutic interventions.
- Future applications may include studies on interferon signaling pathways.
Frequently Asked Questions
Executive Industry Relevance
Quantification of bioactive type-I interferons is critical for evaluating innate immune activation in antiviral and immunomodulatory drug discovery. This reporter-based assay enables mechanistic de-risking by providing quantitative, pathway-specific readouts of interferon signaling. It supports target validation and lead identification in early discovery by linking compound effects to functional interferon responses.
Strategic Applications in Biopharma R&D
Early Discovery & Target Validation
- Scientific Value: Measures functional interferon activity to validate targets in innate immune pathways.
- Operational Value: Uses engineered reporter cells for sensitive, specific detection of interferon-alpha and beta.
- Predictive Value: Enables assessment of compound-induced interferon responses for go/no-go decisions.
Screening & Assay Development
- Assay Readiness: Generates quantitative, colorimetric outputs compatible with microplate readers for screening campaigns.
- Reproducibility: Standard curve interpolation ensures consistent quantification across experiments and laboratories.
- Scalability: Multi-well format supports medium-throughput screening of immunomodulatory compounds.
Translational & Preclinical Research
- Translational Continuity: Links in vitro interferon measurements to preclinical models of immune activation.
- Biomarker Alignment: Provides a pharmacodynamic readout for interferon pathway modulation in therapeutic development.
- Risk-Adjusted Advancement: Supports decisions on cytokine-related safety and efficacy profiles.
Pipeline & Workflow Integration
The assay fits within the discovery continuum from target validation through lead optimization, delivering functional data that informs early-phase prioritization.
- Discovery Biology: Supports hypothesis testing of interferon pathway activation by test compounds or biologics.
- Screening: Delivers reproducible, quantitative readouts for hit confirmation and SAR development.
- Analytics: Enables interpolation of interferon concentrations from standard curves for data-driven comparisons.
- Translational Research: Connects cellular interferon responses to in vivo immune outcomes.
- Enterprise Reuse: Establishes a reusable platform for interferon quantification across therapeutic areas.
Operational & Enterprise Impact
- Scientific Value: Provides mechanistic insight into interferon signaling with high specificity for bioactive isoforms.
- Operational Value: Standardized protocol with defined incubation and detection steps ensures reproducibility.
- Strategic Value: Improves confidence in target engagement and pathway modulation data.
- Portfolio Impact: Enables risk-based prioritization of candidates based on interferon-related activity.
Implementation Considerations
- Requires expertise in cell culture and cytokine signaling assays.
- Dependent on microplate reader capable of absorbance measurement at 620–655 nm.
- Necessitates standardization of interferon controls and SEAP substrate incubation times.
- Adaptation to primary immune cells may require optimization of reporter sensitivity.
- Limited to type-I interferons; multiplexing would require alternative reporter systems.
Biopharma FAQs
Isolation of Exosomes from the Plasma of HIV-1 Positive Individuals
Related Videos
0 Views
Generation of Immature, Mature and Tolerogenic Dendritic Cells with Differing Metabolic Phenotypes
Related Videos
0 Views
A Macrophage Reporter Cell Assay to Examine Toll-Like Receptor-Mediated NF-kB/AP-1 Signaling on Adsorbed Protein Layers on Polymeric Surfaces
Related Videos
0 Views
Using Reverse Genetics to Manipulate the NSs Gene of the Rift Valley Fever Virus MP-12 Strain to Improve Vaccine Safety and Efficacy
Related Videos
0 Views
Use of Interferon-γ Enzyme-linked Immunospot Assay to Characterize Novel T-cell Epitopes of Human Papillomavirus
Related Videos
0 Views
Vaccinia Reporter Viruses for Quantifying Viral Function at All Stages of Gene Expression
Related Videos
0 Views
Development of an IFN-γ ELISpot Assay to Assess Varicella-Zoster Virus-specific Cell-mediated Immunity Following Umbilical Cord Blood Transplantation
Related Videos
0 Views
High-throughput Quantitative Real-time RT-PCR Assay for Determining Expression Profiles of Types I and III Interferon Subtypes
Related Videos
0 Views
A High Resolution Method to Monitor Phosphorylation-dependent Activation of IRF3
Related Videos
0 Views
Development of a Hepatitis B Virus Reporter System to Monitor the Early Stages of the Replication Cycle
Related Videos
0 Views
Last updated: 22 August 2026